Chemotherapy for neuroblastoma

Last medical review:

Chemotherapy uses anticancer (cytotoxic) drugs to destroy cancer cells. It is usually used to treat neuroblastoma. Your child's healthcare team will consider the stage and risk group, as well as your child's personal needs, to plan the drugs, doses and schedules of chemotherapy. Your child may also receive other treatments.

Most children with intermediate- and high-risk disease will have chemotherapy. Some children with low-risk disease that affects vital organs will be given chemotherapy.

Chemotherapy is given for different reasons. Your child may have chemotherapy to:

  • destroy cancer cells in the body
  • shrink a tumour before surgery (called neoadjuvant chemotherapy)
  • destroy cancer cells left behind after surgery and lower the risk that the cancer will come back (recur) (called adjuvant chemotherapy)
  • relieve pain or control the symptoms of advanced neuroblastoma (called palliative chemotherapy)
  • treat spinal cord compression, a cancer-related emergency that neuroblastoma can cause
Chemotherapy is usually a systemic therapy. This means that the drugs travel through the blood to reach and destroy cancer cells all over the body, including those that may have broken away from the primary tumour. The drugs may be given by mouth or by a needle in a vein (intravenous injection). Sometimes a special device called a central venous catheter may be used to safely give the drugs. It is usually placed during surgery at the start of chemotherapy and left in place until treatment is finished. Find out more about central venous catheter.

Chemotherapy drugs used for neuroblastoma

The most common chemotherapy drugs used to treat neuroblastoma are:

  • cyclophosphamide
  • cisplatin
  • carboplatin
  • vincristine
  • doxorubicin
  • etoposide
  • topotecan
  • melphalan
  • busulfan
  • thiotepa
If neuroblastoma does not respond to drugs used in earlier treatments or if it recurs, these drug combinations may be used:
  • topotecan and cyclophosphamide
  • irinotecan and temozolomide

Side effects

Side effects can happen with any type of treatment for neuroblastoma, but every child's experience is different. Some children have many side effects. Other children have few or none at all.

Chemotherapy may cause side effects because it can damage healthy cells as it kills cancer cells. Side effects can develop any time during, immediately after or a few days or weeks after chemotherapy. Sometimes late side effects develop months or years after chemotherapy. Most side effects go away on their own or can be treated, but some side effects may last a long time or become permanent.

It is hard to say exactly which side effects a child will have, how long they will last and when the child will recover. A child's body seems to handle chemotherapy better than an adult's body. Children usually have less severe side effects and will often recover from them faster than adults.

Side effects of chemotherapy will depend mainly on the type of drug or drugs given, the dose, how the drugs are given and the child's overall health. Some common side effects of chemotherapy drugs used for neuroblastoma are:

Other side effects can develop months or years after treatment for neuroblastoma. Find out more about late effects for neuroblastoma.

Tell the healthcare team if your child has side effects you think might be from chemotherapy. The sooner you tell them of any problems, the sooner they can suggest ways to help your child deal with them.

Information about specific cancer drugs

Details on specific drugs change regularly. Find out more about sources of drug information and where to get details on specific drugs.

Questions to ask about chemotherapy

Find out more about chemotherapy and side effects of chemotherapy. To make the decisions that are right for your child, ask the healthcare team questions about chemotherapy.

Expert review and references

  • Meredith Irwin, MD
  • Daniel Morgenstern, MD
  • American Society of Clinical Oncology. Neuroblastoma. 2018.
  • Lacayo NJ. Pediatric Neuroblastoma. eMedicine/Medscape; 2017. https://emedicine.medscape.com/.
  • Cancer Research UK. Neuroblastoma. Cancer Research UK; 2014.
  • PDQ® Pediatric Treatment Editorial Board. Neuroblastoma Treatment (PDQ®)–Health ProfessionalVersion. Bethesda, MD: National Cancer Institute; 2020. https://www.cancer.gov/.
  • Brodeur GM, Hogarty MD, Bagatell R, Mosse YP, Maris JM. Neuroblastoma. Pizzo PA, Poplack DG, eds.. Principles and Practice of Pediatric Oncology. 7th ed. Philadelphia, PA: Wolters Kluwer; 2016: 30:772–797.
  • PDQ® Pediatric Treatment Editorial Board. Neuroblastoma Treatment (PDQ®)–Patient Version. Bethesda, MD: National Cancer Institute; 2021. https://www.cancer.gov/types/neuroblastoma/patient/neuroblastoma-treatment-pdq.
  • American Cancer Society. Treating Neuroblastoma. 2020. https://www.cancer.org/.
  • Bartholomew, J. Neuroblastoma. Baggott C, Fochtman D, Foley GV & Patterson Kelly, K (eds.). Nursing Care of Children and Adolescents with Cancer and Blood Disorders. 4th ed. APHON; 2011: 30: pp. 1038-1053.
  • Lacayo NJ. Medscape: Pediatric Neuroblastoma Treatment and Management. WebMD LLC; 2012.
  • Joyner BD. Medscape: Neuroblastoma Treatment and Management. WebMD LLC; 2012.
  • Lacayo, NJ. Pediatric neuroblastoma medication. WebMD LLC; 2012.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society